Integrated Collection of Stem Cell Bank Data, a Data Portal for Standardized Stem Cell Information

Andrews, P.W., Baker, D., Benvinisty, N., Miranda, B., Bruce, K.,

¨ stle, O., Choi, M., Choi, Y.-M., Crook, J.M., and Dvorak, P.

Bru

(2015). Points to consider in the development of seed

stocks of pluripotent stem cells for clinical applications:

international Stem Cell Banking Initiative (ISCBI). Regen.

Med. 10, 1–44.

Fujibuchi, W., Goto, S., Migimatsu, H., Uchiyama, I., Ogiwara, A.,

Akiyama, Y., and Kanehisa, M. (1998). DBGET/LinkDB: an integrated database retrieval system. Pac. Symp. Biocomput. 98, 683–

694.

Godard, B., Schmidtke, J., Cassiman, J.J., and Ayme´, S. (2003).

Data storage and DNA banking for biomedical research: informed

8 Stem Cell Reports j Vol. 16 j 1–9 j April 13, 2021

consent, confidentiality, quality issues, ownership, return of

benefits. A professional perspective. Eur. J. Hum. Genet. 11,

S88–S122.

Hug, K. (2009). Banks, repositories and registries of stem cell lines

in Europe: regulatory and ethical aspects. Stem Cell Rev. Rep. 5, 18–

35.

Isasi, R., and Knoppers, B.M. (2011). From banking to international

governance: fostering innovation in stem cell research. Stem Cells

Int. 2011, 498132.

Kim, J.H., Kurtz, A., Yuan, B.Z., Zeng, F., Lomax, G., Loring, J.F.,

Crook, J., Ju, J.H., Clarke, L., Inamdar, M.S., et al. (2017). Report

of the International Stem Cell Banking Initiative workshop activity: current hurdles and progress in seed-stock banking of human pluripotent stem cells. Stem Cells Transl. Med. 6, 1956–

1962.

Knoppers, B.M., and Isasi, R. (2010). Stem cell banking: between

traceability and identifiability. Genome Med. 2, 73.

Kobayashi, N., Lenz, K., and Masuya, H. (2016). RIKEN MetaDatabase: a database platform as a microcosm of linked open data cloud

in the life sciences. In Joint International Semantic Technology

Conference (Springer), pp. 99–115.

Kurtz, A., Seltmann, S., Bairoch, A., Bittner, M.S., Bruce, K.,

Capes-Davis, A., Laurence, D., Johannes, D., Clarke, L., Crook,

J.M., et al. (2018). A standard nomenclature for referencing

and authentication of pluripotent stem cells. Stem Cell Reports

10, 1–6.

Nishizawa, M., Chonabayashi, K., Nomura, M., Tanaka, A., Nakamura, M., Inagaki, A., Nishikawa, M., Takei, I., Oishi, A., Tanabe,

K., et al. (2016). Epigenetic variation between human induced

pluripotent stem cell lines is an indicator of differentiation capacity. Cell Stem Cell 19, 341–354.

Sakurai, K., Kurtz, A., Stacey, G., Sheldon, M., and Fujibuchi, W.

(2016). First proposal of minimum information about a cellular

assay for regenerative medicine. Stem Cells Transl. Med. 5,

1345–1361.

Sasaki, K., Makiyama, T., Yoshida, Y., Wuriyanghai, Y., Kamakura, T., Nishiuchi, S., Hayano, M., Harita, T., Yamamoto, Y.,

Hirose, S., et al. (2016). Patient-specific human induced

pluripotent stem cell model assessed with electrical pacing validates S107 as a potential therapeutic agent for catecholaminergic polymorphic ventricular tachycardia. PLoS One 11,

e0164795.

¨ ller, R., Stachelscheid, H., Bittner,

Seltmann, S., Lekschas, F., Mu

M.S., Zhang, W., Luam, K., Anna, S., Anna, V., Stacey, G.N., et al.

(2015). hPSCreg—the human pluripotent stem cell registry. Nucleic Acids Res. 44, D757–D763.

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem

cells from adult human fibroblasts by defined factors. Cell 31, 861–

872.

Thirumala, S., Goebel, W.S., and Woods, E.J. (2009). Clinical grade

adult stem cell banking. Organogenesis 5, 143–154.

Vasilevsky, N., Johnson, T., Corday, K., Torniai, C., Brush, M., Segerdell, E., Wilson, M., Shaffer, C., Robinson, D., and Haendel,

A Self-archived copy in

Please cite this article in press as: Chen et al., Integrated

Collection

of Stem

Cell Bank

Data, a Data Portal for Standardized Stem Cell InforKyoto University

Research

Information

Repository

mation, Stem Cell Reports (2021), https://doi.org/10.1016/j.stemcr.2021.02.014

https://repository.kulib.kyoto-u.ac.jp

M. (2012). Research resources: curating the new eagle-i discovery

system. Database 2012, bar067.

ment of data, intellectual property, and ethics. Yale J. Health Policy

Law Ethics 9, 52–127.

Wells, C.A., Mosbergen, R., Korn, O., Choi, J., Seidenman, N., Matigian, N.A., Vitale, A.M., and Shepherd, J. (2013). Stemformatics:

visualisation and sharing of stem cell gene expression. Stem Cell

Res. 10, 387–395.

Yaffe, M.P., Noggle, S.A., and Solomon, S.L. (2016). Raising the

standards of stem cell line quality. Nat. Cell Biol. 18, 236.

Winickoff, D.E., Saha, K., and Graff, G.D. (2009). Opening stem

cell research and development: a policy proposal for the manage-

Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., Chandler, J.,

Charge´, S., Heine, H., Isasi, R., Kato, K., Lovell-Badge, R., et al.

(2009). iPS cells: mapping the policy issues. Cell 139, 1032–

1037.

Stem Cell Reports j Vol. 16 j 1–9 j April 13, 2021 9

...